EMBO Member
Stewart Cole
EMBO 2002 | GexC 10–11
Institut Pasteur, Paris, France
A regulatory map of the M. tuberculosis genome
My group uses a multidisciplinary approach to tackle global health problems such as tuberculosis (TB), Buruli ulcer and leprosy. Using screening and genome biology as platforms we are actively involved in discovering new drugs to treat TB. Our goal is to validate pharmacologically five new TB drug targets and to discover a family of compounds for a drug candidate.
Keywords
Genomics / microbial pathogenesis / drug discovery / drug resistance / phylogeography / tuberculosis / leprosy / drug discovery